 | • レポートコード：GIR-107A14942 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、セルトリズマブペゴルのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。セルトリズマブペゴルの種類別市場規模（単回投与バイアル、単回投与プレフィルドシリンジ）、用途別市場規模（クローン病、活動性関節リウマチ、活動性乾癬性関節炎）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・セルトリズマブペゴルの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：UCB ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：単回投与バイアル、単回投与プレフィルドシリンジ ・用途別分析2016年-2026年：クローン病、活動性関節リウマチ、活動性乾癬性関節炎 ・セルトリズマブペゴルの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・セルトリズマブペゴルのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・セルトリズマブペゴルのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・セルトリズマブペゴルの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・セルトリズマブペゴルの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Certolizumab pegol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Certolizumab pegol size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Certolizumab pegol market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Certolizumab pegol market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single-dose vial
Single-dose prefilled syringe
Market segment by Application, can be divided into
Crohn’s disease
Active rheumatoid arthritis
Active psoriatic arthritis
Market segment by players, this report covers
UCB
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Certolizumab pegol
1.2 Classification of Certolizumab pegol by Type
1.2.1 Overview: Global Certolizumab pegol Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Certolizumab pegol Revenue Market Share by Type in 2020
1.2.3 Single-dose vial
1.2.4 Single-dose prefilled syringe
1.3 Global Certolizumab pegol Market by Application
1.3.1 Overview: Global Certolizumab pegol Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Crohn’s disease
1.3.3 Active rheumatoid arthritis
1.3.4 Active psoriatic arthritis
1.4 Global Certolizumab pegol Market Size & Forecast
1.5 Global Certolizumab pegol Market Size and Forecast by Region
1.5.1 Global Certolizumab pegol Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Certolizumab pegol Market Size by Region, (2016-2021)
1.5.3 North America Certolizumab pegol Market Size and Prospect (2016-2026)
1.5.4 Europe Certolizumab pegol Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Certolizumab pegol Market Size and Prospect (2016-2026)
1.5.6 South America Certolizumab pegol Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Certolizumab pegol Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Certolizumab pegol Market Drivers
1.6.2 Certolizumab pegol Market Restraints
1.6.3 Certolizumab pegol Trends Analysis
2 Company Profiles
2.1 UCB
2.1.1 UCB Details
2.1.2 UCB Major Business
2.1.3 UCB Certolizumab pegol Product and Solutions
2.1.4 UCB Certolizumab pegol Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 UCB Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Certolizumab pegol Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Certolizumab pegol Players Market Share
3.2.2 Top 10 Certolizumab pegol Players Market Share
3.2.3 Market Competition Trend
3.3 Certolizumab pegol Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Certolizumab pegol Revenue and Market Share by Type (2016-2021)
4.2 Global Certolizumab pegol Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Certolizumab pegol Revenue Market Share by Application (2016-2021)
5.2 Certolizumab pegol Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Certolizumab pegol Revenue by Type (2016-2026)
6.2 North America Certolizumab pegol Revenue by Application (2016-2026)
6.3 North America Certolizumab pegol Market Size by Country
6.3.1 North America Certolizumab pegol Revenue by Country (2016-2026)
6.3.2 United States Certolizumab pegol Market Size and Forecast (2016-2026)
6.3.3 Canada Certolizumab pegol Market Size and Forecast (2016-2026)
6.3.4 Mexico Certolizumab pegol Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Certolizumab pegol Revenue by Type (2016-2026)
7.2 Europe Certolizumab pegol Revenue by Application (2016-2026)
7.3 Europe Certolizumab pegol Market Size by Country
7.3.1 Europe Certolizumab pegol Revenue by Country (2016-2026)
7.3.2 Germany Certolizumab pegol Market Size and Forecast (2016-2026)
7.3.3 France Certolizumab pegol Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Certolizumab pegol Market Size and Forecast (2016-2026)
7.3.5 Russia Certolizumab pegol Market Size and Forecast (2016-2026)
7.3.6 Italy Certolizumab pegol Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Certolizumab pegol Revenue by Type (2016-2026)
8.2 Asia-Pacific Certolizumab pegol Revenue by Application (2016-2026)
8.3 Asia-Pacific Certolizumab pegol Market Size by Region
8.3.1 Asia-Pacific Certolizumab pegol Revenue by Region (2016-2026)
8.3.2 China Certolizumab pegol Market Size and Forecast (2016-2026)
8.3.3 Japan Certolizumab pegol Market Size and Forecast (2016-2026)
8.3.4 South Korea Certolizumab pegol Market Size and Forecast (2016-2026)
8.3.5 India Certolizumab pegol Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Certolizumab pegol Market Size and Forecast (2016-2026)
8.3.7 Australia Certolizumab pegol Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Certolizumab pegol Revenue by Type (2016-2026)
9.2 South America Certolizumab pegol Revenue by Application (2016-2026)
9.3 South America Certolizumab pegol Market Size by Country
9.3.1 South America Certolizumab pegol Revenue by Country (2016-2026)
9.3.2 Brazil Certolizumab pegol Market Size and Forecast (2016-2026)
9.3.3 Argentina Certolizumab pegol Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Certolizumab pegol Revenue by Type (2016-2026)
10.2 Middle East & Africa Certolizumab pegol Revenue by Application (2016-2026)
10.3 Middle East & Africa Certolizumab pegol Market Size by Country
10.3.1 Middle East & Africa Certolizumab pegol Revenue by Country (2016-2026)
10.3.2 Turkey Certolizumab pegol Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Certolizumab pegol Market Size and Forecast (2016-2026)
10.3.4 UAE Certolizumab pegol Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Certolizumab pegol Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Certolizumab pegol Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Certolizumab pegol Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Certolizumab pegol Revenue (USD Million) by Region (2016-2021)
Table 5. Global Certolizumab pegol Revenue Market Share by Region (2021-2026)
Table 6. UCB Corporate Information, Head Office, and Major Competitors
Table 7. UCB Major Business
Table 8. UCB Certolizumab pegol Product and Solutions
Table 9. UCB Certolizumab pegol Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Global Certolizumab pegol Revenue (USD Million) by Players (2019-2021)
Table 11. Global Certolizumab pegol Revenue Share by Players (2019-2021)
Table 12. Breakdown of Certolizumab pegol by Company Type (Tier 1, Tier 2 and Tier 3)
Table 13. Certolizumab pegol Players Head Office, Products and Services Provided
Table 14. Certolizumab pegol Mergers & Acquisitions in the Past Five Years
Table 15. Certolizumab pegol New Entrants and Expansion Plans
Table 16. Global Certolizumab pegol Revenue (USD Million) by Type (2016-2021)
Table 17. Global Certolizumab pegol Revenue Share by Type (2016-2021)
Table 18. Global Certolizumab pegol Revenue Forecast by Type (2021-2026)
Table 19. Global Certolizumab pegol Revenue by Application (2016-2021)
Table 20. Global Certolizumab pegol Revenue Forecast by Application (2021-2026)
Table 21. North America Certolizumab pegol Revenue by Type (2016-2021) & (USD Million)
Table 22. North America Certolizumab pegol Revenue by Type (2021-2026) & (USD Million)
Table 23. North America Certolizumab pegol Revenue by Application (2016-2021) & (USD Million)
Table 24. North America Certolizumab pegol Revenue by Application (2021-2026) & (USD Million)
Table 25. North America Certolizumab pegol Revenue by Country (2016-2021) & (USD Million)
Table 26. North America Certolizumab pegol Revenue by Country (2021-2026) & (USD Million)
Table 27. Europe Certolizumab pegol Revenue by Type (2016-2021) & (USD Million)
Table 28. Europe Certolizumab pegol Revenue by Type (2021-2026) & (USD Million)
Table 29. Europe Certolizumab pegol Revenue by Application (2016-2021) & (USD Million)
Table 30. Europe Certolizumab pegol Revenue by Application (2021-2026) & (USD Million)
Table 31. Europe Certolizumab pegol Revenue by Country (2016-2021) & (USD Million)
Table 32. Europe Certolizumab pegol Revenue by Country (2021-2026) & (USD Million)
Table 33. Asia-Pacific Certolizumab pegol Revenue by Type (2016-2021) & (USD Million)
Table 34. Asia-Pacific Certolizumab pegol Revenue by Type (2021-2026) & (USD Million)
Table 35. Asia-Pacific Certolizumab pegol Revenue by Application (2016-2021) & (USD Million)
Table 36. Asia-Pacific Certolizumab pegol Revenue by Application (2021-2026) & (USD Million)
Table 37. Asia-Pacific Certolizumab pegol Revenue by Region (2016-2021) & (USD Million)
Table 38. Asia-Pacific Certolizumab pegol Revenue by Region (2021-2026) & (USD Million)
Table 39. South America Certolizumab pegol Revenue by Type (2016-2021) & (USD Million)
Table 40. South America Certolizumab pegol Revenue by Type (2021-2026) & (USD Million)
Table 41. South America Certolizumab pegol Revenue by Application (2016-2021) & (USD Million)
Table 42. South America Certolizumab pegol Revenue by Application (2021-2026) & (USD Million)
Table 43. South America Certolizumab pegol Revenue by Country (2016-2021) & (USD Million)
Table 44. South America Certolizumab pegol Revenue by Country (2021-2026) & (USD Million)
Table 45. Middle East & Africa Certolizumab pegol Revenue by Type (2016-2021) & (USD Million)
Table 46. Middle East & Africa Certolizumab pegol Revenue by Type (2021-2026) & (USD Million)
Table 47. Middle East & Africa Certolizumab pegol Revenue by Application (2016-2021) & (USD Million)
Table 48. Middle East & Africa Certolizumab pegol Revenue by Application (2021-2026) & (USD Million)
Table 49. Middle East & Africa Certolizumab pegol Revenue by Country (2016-2021) & (USD Million)
Table 50. Middle East & Africa Certolizumab pegol Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Certolizumab pegol Picture
Figure 2. Global Certolizumab pegol Revenue Market Share by Type in 2020
Figure 3. Single-dose vial
Figure 4. Single-dose prefilled syringe
Figure 5. Certolizumab pegol Revenue Market Share by Application in 2020
Figure 6. Crohn’s disease Picture
Figure 7. Active rheumatoid arthritis Picture
Figure 8. Active psoriatic arthritis Picture
Figure 9. Global Certolizumab pegol Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Certolizumab pegol Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Certolizumab pegol Revenue Market Share by Region (2016-2026)
Figure 12. Global Certolizumab pegol Revenue Market Share by Region in 2020
Figure 13. North America Certolizumab pegol Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Certolizumab pegol Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Certolizumab pegol Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Certolizumab pegol Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Certolizumab pegol Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Certolizumab pegol Market Drivers
Figure 19. Certolizumab pegol Market Restraints
Figure 20. Certolizumab pegol Market Trends
Figure 21. UCB Recent Developments and Future Plans
Figure 22. Global Certolizumab pegol Revenue Share by Players in 2020
Figure 23. Certolizumab pegol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 24. Global Top 3 Players Certolizumab pegol Revenue Market Share in 2020
Figure 25. Global Top 10 Players Certolizumab pegol Revenue Market Share in 2020
Figure 26. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 27. Global Certolizumab pegol Revenue Share by Type in 2020
Figure 28. Global Certolizumab pegol Market Share Forecast by Type (2021-2026)
Figure 29. Global Certolizumab pegol Revenue Share by Application in 2020
Figure 30. Global Certolizumab pegol Market Share Forecast by Application (2021-2026)
Figure 31. North America Certolizumab pegol Sales Market Share by Type (2016-2026)
Figure 32. North America Certolizumab pegol Sales Market Share by Application (2016-2026)
Figure 33. North America Certolizumab pegol Revenue Market Share by Country (2016-2026)
Figure 34. United States Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Canada Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Mexico Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Europe Certolizumab pegol Sales Market Share by Type (2016-2026)
Figure 38. Europe Certolizumab pegol Sales Market Share by Application (2016-2026)
Figure 39. Europe Certolizumab pegol Revenue Market Share by Country (2016-2026)
Figure 40. Germany Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. France Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. United Kingdom Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Russia Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Italy Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Certolizumab pegol Sales Market Share by Type (2016-2026)
Figure 46. Asia-Pacific Certolizumab pegol Sales Market Share by Application (2016-2026)
Figure 47. Asia-Pacific Certolizumab pegol Revenue Market Share by Region (2016-2026)
Figure 48. China Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Japan Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. South Korea Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. India Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Southeast Asia Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Australia Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. South America Certolizumab pegol Sales Market Share by Type (2016-2026)
Figure 55. South America Certolizumab pegol Sales Market Share by Application (2016-2026)
Figure 56. South America Certolizumab pegol Revenue Market Share by Country (2016-2026)
Figure 57. Brazil Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Argentina Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Middle East and Africa Certolizumab pegol Sales Market Share by Type (2016-2026)
Figure 60. Middle East and Africa Certolizumab pegol Sales Market Share by Application (2016-2026)
Figure 61. Middle East and Africa Certolizumab pegol Revenue Market Share by Country (2016-2026)
Figure 62. Turkey Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Saudi Arabia Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. UAE Certolizumab pegol Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Methodology
Figure 66. Research Process and Data Source
世界のセルトリズマブペゴル市場予測（～2024年） Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Scope of the Report: The global Certolizumab pegol market is valued at xx million USD in 2018 and is expected to reach xx…- Cimzia（セルトリズマブ）治療薬市場：世界及び中国市場分析・予測（～2024年） Cimzia (certolizumab) Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cimzia (certolizumab) Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cimzia (certoliz…
- 世界の若年性黄斑変性症治療市場 2021：企業別、地域別、種類・用途別 The Juvenile Macular Degeneration Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の腫瘍壊死因子阻害薬市場 2021：企業別、地域別、種類・用途別 The Tumor Necrosis Factor Inhibitors Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界のドリペネム市場 2021：企業別、地域別、種類・用途別 The Doripenem market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent d…